首页|他汀类药物在缺血性脑血管病二级预防中的应用效果及其影响因素

他汀类药物在缺血性脑血管病二级预防中的应用效果及其影响因素

扫码查看
[目的]探讨他汀类药物在缺血性脑血管病(ICVD)二级预防中的应用效果及其影响因素.[方法]本院收治的109例ICVD患者,随访1年,死亡1例,失访2例,根据是否再次发生ICVD将患者分为复发组和未复发组,比较两组患者的临床资料,探讨影响他汀类药物预防效果的因素.[结果]纳入的106例患者,其中15例(14.15%)ICVD复发,未复发91例(85.85%).复发组和未复发组的年龄、性别、家族史、吸烟史、饮酒史、白细胞计数、血糖比较,差异均无统计学意义(P>0.05);两组体重指数(BMI)、文化程度、医疗支付方式、合并疾病数量、服用药物种类以及依从性等比较,差异有统计学意义(P<0.05).多因素回归分析显示,BMI高、文化程度低、自费医疗支付、合并疾病数量多、服用药物种类多以及依从性低是他汀类药物在ICVD二级预防中复发的独立危险因素(P<0.05).[结论]他汀类药物在ICVD二级预防中的效果受患者BMI、文化程度、医疗支付方式、合并疾病数量、药物种类及依从性等因素影响,优化二级预防需关注上述因素.
Application Effect and Influencing Factors of Statins in Secondary Prevention of Ischemic Cerebro-vascular Disease
[Objective]To explore the application effect and influencing factors of statins in the secondary prevention of ischemic cerebrovascular disease(ICVD).[Methods]A total of 109 ICVD patients treated in our hospital were followed up for one year.One patient died,and two were lost to follow-up.Patients were divided into a recurrence group and a non-recurrence group based on whether ICVD recurred.Univariate analysis was used to compare the clinical data of the two groups and to explore the factors affecting the preventive effect of statins.[Results]Among the 106 patients,15 cases(14.15%)had ICVD recurrence,while 91 cases(85.85%)did not have recurrence of ICVD.There were no statistically significant differences in age,gender,family history,smoking history,alcohol consumption history,white blood cell count,and blood glucose levels between the recurrence and non-recurrence groups(P>0.05).However,significant differences were found in body mass index(BMI),educational level,medical payment method,number of comorbidities,types of medications taken,and compliance(P<0.05).Multivariate regression analysis showed that high BMI,low edu-cational level,self-payment for medical expenses,a high number of comorbidities,taking multiple types of medications,and low compliance were independent risk factors for recurrence in the secondary prevention of ICVD with statins(P<0.05).[Conclusion]The effect of statins in the secondary prevention of ICVD is influenced by factors such as patients'BMI,educational level,medical payment method,comorbidities,types of medications,and compliance.Optimizing sec-ondary prevention requires attention to these related factors.

Brain IschemiaHydroxymethylglutaryl-CoA Reductase Inhibitors/TURoot Cause Analy-sis

孟婷婷、耿德胜

展开 >

洛阳市第六人民医院药剂科,河南 洛阳 471000

新乡医学院第三附属医院急诊科,河南 新乡 453003

脑缺血 羟甲基戊二酰基CoA还原酶抑制剂/治疗应用 影响因素分析

2024

医学临床研究
湖南省医学会

医学临床研究

影响因子:0.595
ISSN:1671-7171
年,卷(期):2024.41(7)
  • 12